Deep Recovery shows how relationship difficulties present in any recovery/self awareness process can provide new understandings. Recovery is about learning and growth, beyond labels, into recovery initiatives. With Deep Recovery awareness, the process of self-evolution becomes more uncomplicated.
Dr Charles Parker (1942-present) was born in Philadelphia, PA - in West Philly at the old Philadelphia Osteopathic Hospital on 48th and Spruce to a war-nomad family - father Navy, mother a physician (DO) who graduated in 1939 from the same medical hospital. As a child and adult psychiatrist with more than 41 years of experience in the office-trenches Parker brings a fresh clinical street sense to the variety of clinical challenges seen in everyday problems.
From addiction recovery to neurotransmitter measurements and SPECT imaging, Parker encourages a fresh perspective for chronic psychiatric treatment failures. Parker's mission is simple: tell the truth to those who will listen, and the necessary medical change will happen. The truth lives in mind-science itself, and yet the story needs public interpretation. http://www.about.me/drcharlesparker
When Parker wrote "Deep Recovery" in 1992 the world reveled in the psychobabble of recovery and codependency - and his initial keynote presentations were met with edgy disagreement as some feared he challenged their evolving "child within." "Deep Recovery," however, proves useful even today, as it demonstrates with specific examples how labels can impede the recovery process from any repetitive/addictive disorder. Today Parker finds abundant medical support as recovery experts now recognize the complexity of biological problems present in any recovery process. Dopamine receptors matter.
Currently Parker regularly reports new science findings on the award-winning CorePsych Blog [from 2006], and recently finished the second edition of "ADHD Medication Rules: Paying Attention To The Meds For Paying Attention." The same reductionistic thinking of 1992 - present in the recovery movement during those days - remains daily at play in current ADHD psychiatric diagnosis and treatment protocols orchestrated through misleading superficial appearances.
Superficial diagnostic labels for ADHD simply don't provide adequate dynamic targets for the complexity of the multiple, often changing, faces of ADHD. Most importantly, those superficial labels too often encourage unpredictable results - especially in the face of abundant new brain and body science. Fresh laboratory data encourages improved outcomes. "ADHD Medication Rules" provides an introduction to that new brain science in conversational terms.
"Rules" aims at one target: to change the simplistic way too many think about diagnosis and treatment for ADHD. Appreciation for the details on every level of ADHD diagnosis and treatment will encourage improved medication results.
